Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 06 Oct 2022 for Global Blood Therapeutics, Inc..
Filing timeline
BuySaleNazila Habibizad
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Nazila Habibizad: trading record in brief
Nazila Habibizad discloses dealings in Global Blood Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 1 March 2022 to 5 October 2022, the count stands at 20 filings.
No open-market purchase appears, only 1 sale worth €312k. Other entries cover 5 share grants and 12 option exercises.
On 6 October 2022 came the latest disclosure, a transaction in Global Blood Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nazila Habibizad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
39,680 sharesCommon StockSEC:0000899243-22-033147:0
3,500 shares0Common StockSEC:0000899243-22-032687:0
23,597 shares@ US$12.9549.7% of flowCommon StockSEC:0000899243-22-032264:0
414 shares@ US$25.371.6% of flowCommon StockSEC:0000899243-22-030480:0
4,678 shares@ US$67.1948.6% of flowCommon StockSEC:0000899243-22-029235:0
1,518 sharesCommon StockSEC:0000899243-22-027638:0
1,558 sharesCommon StockSEC:0000899243-22-013882:0
1,671 sharesCommon StockSEC:0000899243-22-009259:0
8 of 8 declarations
